The patient was a 32-year-old pregnant woman. Her medical history included eight pregnancies, no full-term births, no premature births, seven spontaneous abortions, and no live births. Hypertension (blood pressure 140/95) and proteinuria developed in her seventh month of pregnancy. Fetal distress, which had not been apparent earlier in the pregnancy, also was detected. Her medical history was remarkable for seven spontaneous abortions and anticardiolipin antibodies, for which she was being treated with prednisone. She was treated with magnesium sulfate, and a cesarean section was performed. A healthy, 2-kg baby with Apgar scores of 8 and 10 was delivered. The mother's blood pressure remained elevated after delivery, and she was treated with metoprolol tartrate and hydrochlorthiazide. Two days after delivery, epistaxis developed. Three days after delivery, petechiae and easy bruising were apparent, anemia and thrombocytopenia developed, and liver function values were elevated (Table 1) . Test results for prothrombin time (PT), partial thromboplastin time (PTT), and fibrinogen degradation products (FDPs) were normal, and the fibrinogen level was elevated at 540 mg/dL (5.4 g/L). The peripheral smear showed moderate anisocytosis and nucleated red cells but no schistocytes. A diagnosis of the hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome was made. She was treated with supportive care. Four days after delivery, the patient's platelet count and liver function test results began to return to normal. She was discharged from the hospital and has completely recovered.
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Clinical Background
The HELLP syndrome is characterized by microangiopathic hemolytic anemia, elevated levels of liver enzymes, and thrombocytopenia. 1, 2 Although the criteria used to diagnose the /L HELLP syndrome patients often first complain of nausea and vomiting, pain in the right upper abdominal quadrant, and malaise. The coagulation profile typically includes normal results on tests for PT, PTT, fibrinogen, and FDPs. Approximately 70% of cases occur preterm, and 30% occur postpartum. Of those that present postpartum, onset is usually within 48 hours of delivery. 3 Most investigators believe that the HELLP syndrome is part of the spectrum of preeclampsia, which is defined as hypertension plus proteinuria, peripheral edema, or both and typically appears in the third trimester. 4 The differences between the two syndromes are that hypertension is not required for the diagnosis of HELLP, and patients with preeclampsia do not have hemolysis or elevated levels of liver enzymes. The two syndromes may share some symptoms because thrombocytopenia is relatively common in preeclampsia. 5 Some authors believe that preeclampsia, HELLP, and disseminated intravascular coagulation (DIC) overlap, although this idea is controversial. DIC has been reported in 4% to 38% of cases of HELLP, while some investigators believe that evidence of DIC can be found in all cases if sensitive tests are used.
3 ' 6 On the other hand, Burrows found that thrombin, which is a necessary component of DIC, does not play a major role in the thrombocytopenia of preeclampsia and that other markers of DIC are absent in HELLP and preeclampsia. 
Role of the Laboratory
The laboratory plays a key role in differentiating HELLP from other disorders that can have similar clinical or laboratory presentations (Table 2) . These disorders include DIC, acute fatty liver of pregnancy (AFLP), thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), and idiopathic thrombocytopenic purpura (ITP), all of which may include thrombocytopenia and bleeding. 3, 7 The fundamental abnormality in DIC is circulating thrombin, which leads to formation of fibrin thrombi in the microcirculation, frequently resulting in microangiopathic hemolysis and organ dysfunction. Compensatory fibrinolysis is almost always present. Laboratory test abnormalities include prolonged PTT and PT, low fibrinogen level, elevated levels of FDPs, and thrombocytopenia. In DIC unrelated to liver disease, liver function test results are usually normal, although the LDH level may be elevated as a result of hemolysis. The causes of DIC are diverse, but in obstetric patients, the differential diagnosis includes retained dead fetus, retained placenta, sepsis, abruptio placentae, and amniotic fluid embolism.
In AFLP, there is acute hepatic failure, with extremely abnormal results on liver function tests as compared with the more mild abnormalities TTP/HUS may show laboratory findings similar to those of HELLP, including thrombocytopenia, microangiopathic hemolysis, and normal values on PT, PTT, fibrinogen, and FDP tests. Evidence of renal disease exists, however, with elevated levels of creatinine and blood urea nitrogen. Fever and neurologic changes also may develop. Patients with ITP have thrombocytopenia, sometimes severe, but no abnormal results on coagulation or liver function tests, and no hemolysis. In each of these disorders, with the exception of ITP, the LDH level may be elevated. LDH isoenzymes may help distinguish between hemolysis and liver disease, especially in patients in whom the presence of liver dysfunction is uncertain. In addition, hemolysis is characterized by a low to undetectable haptoglobin level and an elevated reticulocyte count.
In this patient, DIC and AFLP were excluded as diagnostic possibilities by the normal results for PT and PTT, appropriately elevated (for lateterm pregnancy) fibrinogen level, and the absence of FDPs. The presence of liver function abnormalities and absence of renal dysfunction, neurologic changes, and fever excluded TTP/HUS as a diagnostic consideration. The peripheral smear was consistent with anemia but was not informative otherwise.
The treatment of preterm HELLP is delivery. The decision to induce labor, however, depends on fetal maturity and clinical and laboratory findings. Disagreement exists about what findings constitute an indication for delivery. In general, before 34 weeks' gestation, women with no signs of bleeding or DIC can be treated with supportive care, and the pregnancy can be continued until the fetus is more mature. Even when the patient experiences bleeding or DIC before 34 weeks, treating the patient and prolonging the gestation may be possible. If the pregnancy has passed 34 weeks, delivery can be performed as indicated by the clinical situation. Conversely, those who consider DIC a component of all cases of HELLP believe that immediate delivery is always indicated. 3 ' 4 Still others believe that immediate delivery is indicated only for patients with severe thrombocytopenia. 3, 8 Postpartum HELLP is treated with supportive care. In both antepartum and postpartum HELLP, the syndrome usually begins to resolve within 48 hours. The risk of recurrence in subsequent pregnancies is estimated to be 3% to 4%. 3 Maternal and fetal morbidity range from 0% to 24% and 8% to 60%, respectively. 
Conclusion
The HELLP syndrome must be recognized and distinguished from several other disorders that can have a similar presentation. These disorders include DIC, AFLP, TTP/HUS, and ITP. The treatment of these disorders is very different from that of the HELLP syndrome, and the treatment chosen can have a profound impact on maternal and fetal outcome. Although the clinical presentation of these disorders may be different, the laboratory often plays a critical role in distinguishing them. Laboratory assessment for thrombocytopenia, liver dysfunction, coagulation test abnormalities, and kidney function are key. Rapid and accurate diagnosis can prevent maternal and fetal morbidity and mortality.®
